Class I Recall

Mylan Pharmaceuticals Inc

Product
Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled Pens per carton (NDC 49502-0196-75), Rx only, Manufactured in Malaysia for: Mylan Specialty L.P., Morgantown, WV, 26505.
Reason
Labeling: Missing Label: label missing from some Semglee prefilled pens.
Classification
Class I
Status
Terminated
Lot
Batch # BF20003118, Exp. August 2022
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Mylan Pharmaceuticals Inc — Class I Recall | MedicineWatch US